{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T08:21:12Z","timestamp":1787473272800,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prrv.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:57:24Z","timestamp":1769702244000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The need to restudy SABA regimens on discharge of children with an acute asthma exacerbation: A scoping review"],"prefix":"10.1016","volume":"59","author":[{"given":"Deborah Yujie","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Elnazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prrv.2026.01.005_b0005","article-title":"Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life","volume":"132","author":"Gwak","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.prrv.2026.01.005_b0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01397-2023","article-title":"The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma","volume":"63","author":"Russell","year":"2024","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.prrv.2026.01.005_b0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0535","article-title":"Early-life exposure to air pollution and childhood asthma cumulative incidence in the ECHO CREW Consortium","volume":"7","author":"Zanobetti","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.prrv.2026.01.005_b0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.chest.2016.10.028","article-title":"Has asthma medication use caught up with the evidence?","volume":"151","author":"Sadatsafavi","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2026.01.005_b0025","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2025. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2025\/05\/GINA-Strategy-Report_2025-WEB-WMS.pdf."},{"key":"10.1016\/j.prrv.2026.01.005_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.08.014","article-title":"The impact of inappropriate use of short-acting beta agonists in asthma","volume":"131","author":"FitzGerald","year":"2017","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.prrv.2026.01.005_b0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM199202203260801","article-title":"The use of \u03b2-agonists and the risk of death and near death from asthma","volume":"326","author":"Spitzer","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.prrv.2026.01.005_b0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.epirev.a017979","article-title":"Epidemiologic studies of beta agonists and asthma deaths","volume":"20","author":"Pearce","year":"1998","journal-title":"Epidemiol Rev"},{"issue":"9","key":"10.1016\/j.prrv.2026.01.005_b0045","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1183\/09031936.94.07091602","article-title":"Patterns of increasing \u03b2-agonist use and the risk of fatal or near-fatal asthma","volume":"7","author":"Suissa","year":"1994","journal-title":"Eur Respir J"},{"issue":"8728","key":"10.1016\/j.prrv.2026.01.005_b0050","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0140-6736(90)93098-A","article-title":"Regular inhaled beta-agonist treatment in bronchial asthma","volume":"336","author":"Sears","year":"1990","journal-title":"Lancet"},{"issue":"9743","key":"10.1016\/j.prrv.2026.01.005_b0055","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(10)61158-0","article-title":"Call for withdrawal of LABA single-therapy inhaler in asthma","volume":"376","author":"Beasley","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.prrv.2026.01.005_b0060","article-title":"The paradoxes of asthma management: time for a new approach?","volume":"50","author":"O\u2019Byrne","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.prrv.2026.01.005_b0065","first-page":"2","article-title":"Hospital discharge using salbutamol as required after acute attacks of wheeze in children: a service evaluation","volume":"109","author":"Connett","year":"2023","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.prrv.2026.01.005_b0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/archdischild-2023-326739","article-title":"Analysis of protocol recommendations for treatment of asthma exacerbations in children: a PERN study","volume":"109","author":"Craig","year":"2024","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.prrv.2026.01.005_b0075","article-title":"Conflicting asthma protocols cause confusion in primary care","volume":"360","author":"Keeley","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.prrv.2026.01.005_b0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/archdischild-2023-326247","article-title":"Emergency department discharge practices for children with acute wheeze and asthma","volume":"109","author":"Hannah","year":"2024","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.prrv.2026.01.005_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200216010-00001","article-title":"Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis","volume":"16","author":"Makhlouf","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.prrv.2026.01.005_b0090","unstructured":"DrugBank. Salbutamol. 2025. Available from: https:\/\/go.drugbank.com\/drugs\/DB01001."},{"key":"10.1016\/j.prrv.2026.01.005_b0095","unstructured":"NHS Transformation Partners. Salbutamol recommendations \u2013 asthma toolkit. 2025. Available from: https:\/\/www.transformationpartners.nhs.uk\/wp-content\/uploads\/2017\/10\/Salbutamol-recommendation-_asthma-toolkit.docx."},{"issue":"2","key":"10.1016\/j.prrv.2026.01.005_b0100","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01858-2019","article-title":"SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting \u03b22-agonist use in asthma","volume":"55","author":"Cabrera","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.01.005_b0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anai.2012.08.014","article-title":"Short-acting \u03b2-agonist use and prediction of future asthma-related outcomes","volume":"109","author":"Stanford","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1\u20133","key":"10.1016\/j.prrv.2026.01.005_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2005.12.060","article-title":"\u03b2-Adrenoceptor responses of the airways: for better or worse?","volume":"533","author":"Broadley","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.prrv.2026.01.005_b0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/CRIAI:31:2:197","article-title":"Clinical concerns with inhaled beta2-agonists: adult asthma","volume":"31","author":"Cockcroft","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.prrv.2026.01.005_b0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0091-6749(96)70282-8","article-title":"Salbutamol-induced increased airway responsiveness to allergen","volume":"97","author":"Bhagat","year":"1996","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.prrv.2026.01.005_b0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1365-2222.2001.01014.x","article-title":"Effect of salmeterol on allergen-induced airway inflammation","volume":"31","author":"Boulet","year":"2001","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.prrv.2026.01.005_b0130","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1164\/ajrccm.156.6.96-08042","article-title":"Effect of regular inhaled albuterol on allergen-induced late responses","volume":"156","author":"Gauvreau","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.prrv.2026.01.005_b0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/ajrccm.153.1.8542164","article-title":"Effect of regular inhaled albuterol on exercise-induced bronchoconstriction","volume":"153","author":"Inman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.prrv.2026.01.005_b0140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1183\/09031936.03.00067503","article-title":"Bronchodilator tolerance","volume":"21","author":"Wraight","year":"2003","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.prrv.2026.01.005_b0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00002018-199411040-00005","article-title":"The beta-2-agonist controversy","volume":"11","author":"Sears","year":"1994","journal-title":"Drug Saf"},{"issue":"17","key":"10.1016\/j.prrv.2026.01.005_b0150","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJM199210223271704","article-title":"Tolerance to the nonbronchodilator effects of inhaled beta2-agonists","volume":"327","author":"O\u2019Connor","year":"1992","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.prrv.2026.01.005_b0155","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/thx.51.10.1051","article-title":"Functional antagonism: tolerance produced by inhaled beta2-agonists","volume":"51","author":"Cockcroft","year":"1996","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.prrv.2026.01.005_b0160","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1164\/ajrccm.158.3.9802069","article-title":"Potential masking effects of salmeterol on airway inflammation","volume":"158","author":"McIvor","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.prrv.2026.01.005_b0165","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01046-2019","article-title":"GINA 2019: a fundamental change in asthma management","volume":"53","author":"Reddel","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.01.005_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13601-020-00316-z","article-title":"New approach to intermittent and mild asthma therapy","volume":"10","author":"Kuprys-Lipinska","year":"2020","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"10.1016\/j.prrv.2026.01.005_b0175","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1378\/chest.128.4.1968","article-title":"Asthma quality-of-care markers using administrative data","volume":"128","author":"Schatz","year":"2005","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.prrv.2026.01.005_b0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.anai.2015.03.002","article-title":"Factors associated with high short-acting \u03b22-agonist use in urban children","volume":"114","author":"Butz","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.prrv.2026.01.005_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100733","article-title":"Anxiety among pediatric asthma patients and parents","volume":"16","author":"Rogulj","year":"2023","journal-title":"World Allergy Organ J"},{"issue":"3","key":"10.1016\/j.prrv.2026.01.005_b0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/2230-8229.189128","article-title":"Efficacy of patient discharge instructions","volume":"23","author":"Sudersanadas","year":"2016","journal-title":"J Fam Community Med"},{"key":"10.1016\/j.prrv.2026.01.005_b0195","unstructured":"NHS England. National bundle of care for children and young people with asthma: phase one. 2021. Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2021\/09\/B0606-National-bundle-of-care-for-children-and-young-people-with-asthma-phase-one-September-2021.pdf."},{"issue":"9","key":"10.1016\/j.prrv.2026.01.005_b0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/archdischild-2024-327447","article-title":"Home use of short-acting beta agonists by children with asthma: a multicentre digital prospective study","volume":"110","author":"Gonsard","year":"2025","journal-title":"Arch Dis Child"},{"issue":"10118","key":"10.1016\/j.prrv.2026.01.005_b0205","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2026.01.005_b0210","first-page":"38","article-title":"Should an inhaled corticosteroid accompany each dose of fast-acting beta2-agonist?","volume":"50","author":"Hendeles","year":"2024","journal-title":"Paediatr Respir Rev"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054226000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054226000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T07:49:00Z","timestamp":1787471340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054226000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S1526054226000047"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2026.01.005","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The need to restudy SABA regimens on discharge of children with an acute asthma exacerbation: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}